Related Experiment Video
Updated: May 24, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hypoglycemia in critically ill children
E Vincent S Faustino1, Eliotte L Hirshberg, Clifford W Bogue
1Yale University School of Medicine, New Haven, Connecticut 06520, USA. vince.faustino@yale.edu
Insights
Hypoglycemia in critically ill children is a concern. Defining it as <40-45 mg/dl in neonates and <60-65 mg/dl in children is suggested, as lower levels correlate with worse outcomes.
Area of Science:
- Pediatric Critical Care Medicine
- Neonatal Intensive Care
- Pediatric Endocrinology
Background:
- Glycemic control in critically ill patients often involves intravenous insulin, raising concerns about hypoglycemia, particularly in children.
- Limited research exists on the specific impact of hypoglycemia in pediatric and neonatal populations.
- This review addresses the existing literature on hypoglycemia in critically ill neonates and children.
Purpose of the Study:
- To systematically review the literature on hypoglycemia in critically ill neonates and children.
- To propose evidence-based definitions for hypoglycemia in these vulnerable patient groups.
- To identify risk factors and suggest preventive strategies for hypoglycemia.
Main Methods:
- A systematic literature review was conducted up to August 2011.
- Databases searched included PubMed, Ovid MEDLINE, and ISI Web of Science.
- Search terms focused on "hypoglycemia" and "critical illness" in pediatric populations (0-18 years).
Main Results:
- 132 articles were included from an initial 513, highlighting hypoglycemia as a significant concern for pediatric intensivists.
- Suggested hypoglycemia definitions: <40-45 mg/dl in neonates and <60-65 mg/dl in children.
- Lower glucose levels are associated with adverse neurological outcomes, prolonged intensive care unit stays, and increased mortality.
Conclusions:
- Current research often focuses on spontaneous hypoglycemia, neglecting insulin-induced hypoglycemia.
- Further investigation into risk factors and outcomes of insulin-induced hypoglycemia is crucial.
- Implementing precise monitoring and computerized protocols can help prevent hypoglycemia and improve outcomes.
Background:
The practice of glycemic control with intravenous insulin in critically ill patients has brought clinical focus on understanding the effects of hypoglycemia, especially in children. Very little is published on the impact of hypoglycemia in this population. We aimed to review the existing literature on hypoglycemia in critically ill neonates and children.
Methods:
We performed a systematic review of the literature up to August 2011 using PubMed, Ovid MEDLINE and ISI Web of Science using the search terms "hypoglycemia or hypoglyc*" and "critical care or intensive care or critical illness". Articles were limited to "all child (0-18 years old)" and "English".
Results:
A total of 513 articles were identified and 132 were included for review. Hypoglycemia is a significant concern among pediatric and neonatal intensivists. Its definition is complicated by the use of a biochemical measure (i.e., blood glucose) for a pathophysiologic problem (i.e., neuroglycopenia). Based on associated outcomes, we suggest defining hypoglycemia as <40-45 mg/dl in neonates and <60-65 mg/dl in children. Below the suggested threshold values, hypoglycemia is associated with worse neurological outcomes, increased intensive care unit stay, and increased mortality. Disruptions in carbohydrate metabolism increase the risk of hypoglycemia incritically ill children. Prevention of hypoglycemia, especially in the setting of intravenous insulin use, will be best accomplished by the combination of accurate measuring techniques, frequent or continuous glucose monitoring, and computerized insulin titration protocols.
Conclusion:
Studies on hypoglycemia in critically ill children have focused on spontaneous hypoglycemia. With the current practice of maintaining blood glucose within a narrow range with intravenous insulin, the risk factors and outcomes associated with insulin-induced hypoglycemia should be rigorously studied to prevent hypoglycemia and potentially improve outcomes of critically ill children.
Related Concept Videos
Hypoglycemia and Glucagon
Hypoglycemia
Diabetic Ketoacidosis l: Introduction
Hyperglycemia
Diabetic Ketoacidosis ll: Pathophysiology
Type I Diabetes III: Clinical Manifestations

